abstract |
Hepatitis C virus inhibitors are disclosed having the general formula: n n n wherein R 1 , R 2 , R 3 , R′, B, Y and X are described in the description. n Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed. |